{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:20:54Z","timestamp":1789147254054,"version":"build-2803163510"},"reference-count":122,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD), the most common cause of dementia, causes irreversible memory loss and cognitive deficits. Current AD drugs do not significantly improve cognitive function or cure the disease. Novel bioproducts are promising options for treating a variety of diseases, including neurodegenerative disorders. Targeting the epigenetic apparatus with bioactive compounds (epidrugs) may aid AD prevention treatment. The aims of this study were to determine the composition of a porcine brain-derived extract Nosustrophine, and whether treating young and older trigenic AD mice produced targeted epigenetic and neuroprotective effects against neurodegeneration. Nosustrophine regulated AD-related APOE and PSEN2 gene expression in young and older APP\/BIN1\/COPS5 mice, inflammation-related (NOS3 and COX-2) gene expression in 3\u20134-month-old mice only, global (5mC)- and de novo DNA methylation (DNMT3a), HDAC3 expression and HDAC activity in 3\u20134-month-old mice; and SIRT1 expression and acetylated histone H3 protein levels in 8\u20139-month-old mice. Mass spectrometric analysis of Nosustrophine extracts revealed the presence of adenosylhomocysteinase, an enzyme implicated in DNA methylation, and nicotinamide phosphoribosyltransferase, which produces the NAD+ precursor, enhancing SIRT1 activity. Our findings show that Nosustrophine exerts substantial epigenetic effects against AD-related neurodegeneration and establishes Nosustrophine as a novel nutraceutical bioproduct with epigenetic properties (epinutraceutical) that may be therapeutically effective for prevention and early treatment for AD-related neurodegeneration.<\/jats:p>","DOI":"10.3390\/pharmaceutics14112447","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T02:34:58Z","timestamp":1668393298000},"page":"2447","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"14","author":[{"given":"Olaia","family":"Mart\u00ednez-Iglesias","sequence":"first","affiliation":[{"name":"EuroEspes Biomedical Research Center, International Center of Neuroscience and Genomic Medicine, 15165 Bergondo, Corunna, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinogran","family":"Naidoo","sequence":"additional","affiliation":[{"name":"EuroEspes Biomedical Research Center, International Center of Neuroscience and Genomic Medicine, 15165 Bergondo, Corunna, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Carrera","sequence":"additional","affiliation":[{"name":"EuroEspes Biomedical Research Center, International Center of Neuroscience and Genomic Medicine, 15165 Bergondo, Corunna, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Corzo","sequence":"additional","affiliation":[{"name":"EuroEspes Biomedical Research Center, International Center of Neuroscience and Genomic Medicine, 15165 Bergondo, Corunna, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-4037","authenticated-orcid":false,"given":"Ram\u00f3n","family":"Cacabelos","sequence":"additional","affiliation":[{"name":"EuroEspes Biomedical Research Center, International Center of Neuroscience and Genomic Medicine, 15165 Bergondo, Corunna, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-021-00833-4","article-title":"The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening","volume":"13","author":"Abdelnour","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"ref_2","unstructured":"GBD 2019 Dementia Forecasting Collaborators (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health, 7, e105\u2013e125."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"133807","DOI":"10.1016\/j.neulet.2018.09.018","article-title":"Pharmacogenomics of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"726","author":"Cacabelos","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_4","first-page":"1673","article-title":"Molecular genetics of Alzheimer\u2019s disease and ageing","volume":"27","author":"Cacabelos","year":"2005","journal-title":"Methods Find Exp. Clin. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn.2016.165","article-title":"Ventral tegmental area: Cellular heterogeneity, connectivity and behaviour","volume":"18","author":"Morales","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.celrep.2016.01.070","article-title":"Regulates Aversive Contextual Learning and Associated In Vivo Synaptic Plasticity in the Hippocampus","volume":"14","author":"Broussard","year":"2016","journal-title":"Cell Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrn3381","article-title":"The brain reward circuitry in mood disorders","volume":"14","author":"Russo","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/WCO.0000000000000345","article-title":"Quantitative MRI to understand Alzheimer\u2019s disease pathophysiology","volume":"29","author":"Bozzali","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Cacabelos, R. (2020). Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093059"},{"key":"ref_11","first-page":"20","article-title":"Alzheimer\u2019s Disease: Current treatments and potential new agents","volume":"44","author":"Niki","year":"2019","journal-title":"US Pharm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.phrs.2017.11.028","article-title":"Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer\u2019s disease","volume":"129","author":"Sadhukhan","year":"2018","journal-title":"Pharm. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3233\/JAD-132741","article-title":"Nutraceuticals: A novel concept in prevention and treatment of Alzheimer\u2019s disease and related disorders","volume":"42","author":"Farias","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2174\/1568026619666191202155738","article-title":"Neuroprotection with natural antioxidants and nutraceuticals in the context of brain cell degeneration: The epigenetic connection","volume":"19","author":"Carrera","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fgene.2019.00079","article-title":"compounds as epigenetic modulating agents in cancer","volume":"10","author":"Marchat","year":"2019","journal-title":"Front. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(09)70262-5","article-title":"Epigenetic mechanisms in neurological diseases: Genes, syndromes, and therapies","volume":"8","author":"Urdinguio","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.neuron.2013.10.023","article-title":"The emerging field of neuroepigenetics","volume":"80","author":"Sweatt","year":"2013","journal-title":"Neuron"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cacabelos, R., Tellado, I., and Cacabelos, P.R. (2019). The epigenetic machinery in the life cycle and pharmacoepigenetics. Pharmacoepigenetics, Academic Press. Chapter 1.","DOI":"10.1016\/B978-0-12-813939-4.00001-2"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mp.2016.242","article-title":"Opening up the DNA methylome of dementia","volume":"22","author":"Esteller","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.arr.2013.05.003","article-title":"Epigenetic mechanisms in Alzheimer\u2019s disease: Implications for pathogenesis and therapy","volume":"12","author":"Wang","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cacabelos, R., Carril, J.C., Cacabelos, N., Kazantsev, A.G., Vostrov, A.V., Corzo, L., Cacabelos, P., and Goldgaber, D. (2019). Sirtuins in Alzheimer\u2019s Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051249"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wu, C.Y., Hu, H.Y., Chow, L.H., Chou, Y.J., Huang, N., Wang, P.N., and Li, C.P. (2015). The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130993"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/JEP.S35326","article-title":"Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: A review","volume":"4","author":"Colucci","year":"2012","journal-title":"J. Exp. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00213-009-1706-1","article-title":"A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer\u2019s disease","volume":"207","author":"Akhondzadeh","year":"2010","journal-title":"Psychopharmacology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-008-1351-0","article-title":"Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease","volume":"202","author":"Schaeffer","year":"2009","journal-title":"Psychopharmacology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/156720510791050911","article-title":"Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline","volume":"7","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10072-021-05089-2","article-title":"Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: Review of the literature and outcomes","volume":"42","author":"Fiani","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/dta.1817","article-title":"Peptide profiling of internet-obrained cerebrolysin using high performance liquid chromatography-electrospray ionization ion trap and ultra high performance liquid chromatography-ion mobility-quadrupole time of flight mass spectrometry","volume":"7","author":"Gevaert","year":"2015","journal-title":"Drug Test Anal."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnins.2019.00038","article-title":"Innovative Therapy for Alzheimer\u2019s Disease-With Focus on Biodelivery of NGF","volume":"13","author":"Mitra","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"105563","DOI":"10.1016\/j.nbd.2021.105563","article-title":"Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer\u2019s disease mouse model at an advanced pathological stage","volume":"162","author":"Gonzalez","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.neuropharm.2009.11.002","article-title":"Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice","volume":"58","author":"Hou","year":"2010","journal-title":"Neuropharmacology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-016-0119-y","article-title":"Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: Emerging therapeutic modality for Alzheimer\u2019s Disease","volume":"11","author":"Kazim","year":"2016","journal-title":"Mol. Neurodeg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01088335","article-title":"Variation of favism-inducing factors (vicine, convicine and L-DOPA) during pod development in Vicia faba L.","volume":"47","author":"Burbano","year":"1995","journal-title":"Plant Foods Hum. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Flurkey, K., Currer, J.M., and Harrison, D.E. (2007). Mouse models in aging research. The Mouse in Biomedical Research, Academic Press. [2nd ed.].","DOI":"10.1016\/B978-012369454-6\/50074-1"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4161\/cam.5.4.16986","article-title":"The roles of amyloid precursor protein (APP) in neurogenesis, implications to pathogenesis and therapy of Alzheimer disease (AD)","volume":"5","author":"Zhou","year":"2011","journal-title":"Cell Adh. Migr."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mahajan, U.V., Varma, V.R., Griswold, M.E., Blackshear, C.T., An, Y., Oommen, A.M., Varma, S., Troncoso, J.C., Pletnikova, O., and O\u2019Brien, R. (2020). Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003439"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S1357-2725(99)00053-9","article-title":"In vitro processing of amyloid precursor protein by cathepsin D","volume":"31","author":"Sadik","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: Targeting the Cholinergic System","volume":"14","author":"Guimaraes","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1074\/jbc.M112.417071","article-title":"The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins","volume":"288","author":"Helwig","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_41","first-page":"5163","article-title":"Nicotinamide phosphoribosyltransferase-related signaling pathway in early Alzheimer\u2019s disease mouse models","volume":"20","author":"Xing","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_42","first-page":"a006304","article-title":"Presenilins and \u03b3-secretase: Structure, function, and role in Alzheimer Disease","volume":"2","author":"Iwatsubo","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_43","first-page":"331","article-title":"Comparative Characterization Profile of Transgenic Mouse Models of Alzheimer \u2018s Disease","volume":"2","author":"Carrera","year":"2017","journal-title":"J. Genom. Med. Pharm."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Iglesias, O., Naidoo, V., Carrera, I., and Cacabelos, R. (2022). Epigenetic studies in the male APP\/BIN1\/COPS5 triple-transgenic mouse model of Alzheimer\u2019s disease. Int. J. Mol. Sci, 23.","DOI":"10.3390\/ijms23052446"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","article-title":"Dopamine and Dopamine Receptors in Alzheimer\u2019s Disease: A Systematic Review and Network Meta-Analysis","volume":"11","author":"Pan","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3233\/JAD-200276","article-title":"Computational Modeling of Catecholamines Dysfunction in Alzheimer\u2019s Disease at Pre-Plaque Stage","volume":"77","author":"Caligiore","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.neurobiolaging.2007.11.010","article-title":"Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer\u2019s disease","volume":"30","author":"Richter","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-143006","article-title":"Biomarkers in sporadic and familial Alzheimer\u2019s disease","volume":"47","author":"Lista","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrneurol.2012.156","article-title":"Gene expression profiling in human neurodegenerative disease","volume":"8","author":"Kirby","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: Risk, mechanisms, and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"43506","DOI":"10.18632\/oncotarget.16490","article-title":"The association between the MAPT polymorphisms and Alzheimer\u2019s disease risk: A meta-analysis","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-170639","article-title":"ABC transporters are key players in Alzheimer\u2019s disease","volume":"61","author":"Pereira","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"630003","DOI":"10.3389\/fphar.2021.630003","article-title":"A computational exploration of the molecular network associated to neuroinflammation in Alzheimer\u2019s Disease","volume":"12","author":"Gressier","year":"2021","journal-title":"Front. Pharm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/13543784.8.10.1521","article-title":"COX-2 and Alzheimer\u2019s disease: Potential roles in inflammation and neurodegeneration","volume":"8","year":"1999","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Iglesias, O., Carrera, I., Carril, J.C., F\u00e9rnandez-Novoa, L., Cacabelos, N., and Cacabelos, R. (2020). DNA methylation in neurodegenerative and cerebrovascular disorders. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062220"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Iglesias, O., Naidoo, V., Cacabelos, N., and Cacabelos, R. (2022). Epigenetic Biomarkers as diagnostic tools for Neurodegenerative Disorders. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010013"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnagi.2013.00016","article-title":"The role of sirtuins in Alzheimer\u2019s disease","volume":"5","author":"Lalla","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"746631","DOI":"10.3389\/fncel.2021.746631","article-title":"Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated with Alzheimer\u2019s Disease","volume":"15","author":"Kurukulasooeiya","year":"2021","journal-title":"Front. Cell Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"143269","DOI":"10.1155\/2011\/143269","article-title":"Targeting HDACs: A promising therapy for Alzheimer\u2019s Disease","volume":"2011","author":"Xu","year":"2011","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_62","first-page":"1","article-title":"What have we learnt from past failures in Alzheimer\u2019s disease drug discovery?","volume":"6","author":"Cacabelos","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000439214","article-title":"Alterations of the neuroinflammatory markers IL-6 and TRAIL in Alzheimer\u2019s Disease","volume":"5","author":"Wu","year":"2015","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5483\/BMBRep.2020.53.1.309","article-title":"Peripheral inflammatory biomarkers in Alzheimer\u2019s disease: A brief review","volume":"53","author":"Park","year":"2020","journal-title":"BMB Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","article-title":"Interleukin-1, neuroinflammation, and Alzheimer\u2019s disease","volume":"22","author":"Mrak","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/NEN.0000000000000176","article-title":"Neuroinflammatory singnals in Alzheimer\u2019s Disease and APP\/PS1 Transgenic Mice: Correlations with plaques, tangles, and oligomeric species","volume":"74","author":"Aso","year":"2015","journal-title":"J. Meuropath. Exp. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.LAB.0000056995.07053.C0","article-title":"Nitric oxide synthase-3 overexpression causes apoptosis and impairs neuronal mitochondrial function: Relevance to alxheimer\u2019s type degeneration","volume":"83","author":"Chiche","year":"2003","journal-title":"Lab. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0531-5131(03)00076-1","article-title":"COX-2 expression in brains of patients with familiar Alzheimer\u2019s disease","volume":"1252","author":"Nogawa","year":"2003","journal-title":"Int. Congr. Ser."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1568007054038201","article-title":"The role of COX-1 and COX-2 in Alzheimer\u2019s Disease Patholgy and the therapeutic potentials of non-steroidal anti-inflammatory drugs","volume":"4","author":"Hoozemans","year":"2005","journal-title":"Curr. Drugs Targ CNS Neurol. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0885-3924(02)00374-3","article-title":"Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer\u2019s disease","volume":"23","author":"Aisen","year":"2002","journal-title":"J. Pain Symptom Manag."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/brain\/aww117","article-title":"Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer\u2019s disease model mice","volume":"139","author":"Woodling","year":"2016","journal-title":"Brain"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Ahmed, S., Jing, Y., Mockett, B.G., Zhang, H., Abraham, W.C., and Liu, P. (2022). Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe\/PS1\u0394E9 Mouse Model of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137316"},{"key":"ref_73","first-page":"335","article-title":"Epigenetic treatment of neurodegenerative disorders","volume":"311","author":"Cacabelos","year":"2019","journal-title":"Histone Modif. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2013.02.021","article-title":"Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer\u2019s disease patients","volume":"34","author":"Chouliaras","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1073858417707457","article-title":"Neuronal DNA Methyltransferases: Epigenetic Mediators between Synaptic Activity and Gene Expression?","volume":"24","author":"Bayraktar","year":"2017","journal-title":"Neuroscientist"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Cui, D., and Xu, X. (2018). DNA methyltransferases, DNA methylation and age-associated cognitive function. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051315"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s12603-014-0552-y","article-title":"Epigenetic nutraceutical diets in Alzheimer\u2019s disease","volume":"18","author":"Davinelli","year":"2014","journal-title":"J. Nutr. Health Aging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"654344","DOI":"10.3389\/fcell.2021.654344","article-title":"Functional and pathological roles of AHCY","volume":"9","author":"Aranda","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jmb.2018.05.014","article-title":"S-adenosylhomocysteine hydrolase partcipitas in DNA methylation inheritance","volume":"430","author":"Ponnulari","year":"2018","journal-title":"J. Mol. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ghazi, T., Arumugam, T., Foolchand, A., and Chuturgoon, A. (2020). The impact of natural dietary compounds on food-borne mycotoxins on DNA methylation and cancer. Cells, 9.","DOI":"10.3390\/cells9092004"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"10221","DOI":"10.1038\/ncomms10221","article-title":"H19IncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydroase","volume":"6","author":"Zhou","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11055-022-01217-3","article-title":"Sirtuins: Role in the regulation of oxidative stress and the pathogenesis of neurodegenerative disorders","volume":"52","author":"Pukhalskaia","year":"2022","journal-title":"Neurosci. Behav. Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10522-017-9685-9","article-title":"Sirtuins, a promising traget in slowing down the ageing process","volume":"18","author":"Grabowska","year":"2017","journal-title":"Biogerontology"},{"key":"ref_84","first-page":"509529","article-title":"The effects of SIRT1 on Alzheimer\u2019s Disease models","volume":"2012","author":"Donmez","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pharmthera.2018.03.004","article-title":"Sirtuin activators and inhibitors: Promises, achievements and challenges","volume":"188","author":"Dai","year":"2018","journal-title":"Pharm. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jpsychires.2012.03.003","article-title":"Ginkgo biloba extract EGb 761\u00ae in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg","volume":"46","author":"Herrschaft","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cns.13095","article-title":"Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761\u00ae","volume":"25","author":"Kandiah","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.freeradbiomed.2006.08.015","article-title":"Protection by EGb 761 against beta-amyloid-induced neurotoxicity: Involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation","volume":"41","author":"Garneau","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC 1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrn3427","article-title":"Histone acetylation: Molecular mnemonics on the chromatin","volume":"14","author":"Tsai","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"585821","DOI":"10.3389\/fphar.2020.585821","article-title":"SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases","volume":"11","author":"Manjula","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","article-title":"SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer\u2019s disease and amyotrophic lateral sclerosis","volume":"26","author":"Kim","year":"2007","journal-title":"EMBO J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.1094637","article-title":"Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase","volume":"303","author":"Brunet","year":"2004","journal-title":"Science"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1073\/pnas.1105304109","article-title":"The c-MYC oncoprotein, the NAMPT enzyme, the SIRT-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedbach loop","volume":"109","author":"Menssen","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","first-page":"1321","article-title":"Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging","volume":"33","author":"Stein","year":"2014","journal-title":"EMBO J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1038\/npjamd.2016.17","article-title":"It takes two to tango: NAD+ and sirtuins in aging\/longevity control","volume":"2","author":"Imai","year":"2016","journal-title":"NPJ Aging Mech. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/acel.12216","article-title":"Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer\u2019s disease-like mouse neurons","volume":"13","author":"Ghosh","year":"2014","journal-title":"Aging Cell"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","article-title":"NAD+ and sirtuins in aging and disease","volume":"24","author":"Imai","year":"2014","journal-title":"Trends Cell Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MCO.0000000000000023","article-title":"Fatty acids and epigenetics","volume":"17","author":"Burdge","year":"2014","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.nut.2014.06.016","article-title":"Inadequate supply of vitamins and DHA in the elderly: Implications for brain aging and Alzheimer-type dementia","volume":"31","author":"Mohajeri","year":"2015","journal-title":"Nutrition"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cbpa.2020.04.008","article-title":"Towards a more precise therapy in cancer: Exploring epigenetic complexity","volume":"57","author":"Esteller","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15592294.2019.1640546","article-title":"Epidrugs: Targeting epigenetic marks in cancer treatment","volume":"14","author":"Furtado","year":"2019","journal-title":"Epigenetics"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1677\/ERC-07-0144","article-title":"Anti-estrogenic actions of histone deacetylase inhibitors in MCF-7 breast cancer cells","volume":"14","author":"Aranda","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12974-020-02028-4","article-title":"Neuroprotective epi-drugs quench the inflammatory response and microglial\/macrophage activation in a mouse model of permanent brain ischemia","volume":"17","author":"Mota","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-2011-101629","article-title":"Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer\u2019s amyloid-induced mitochondrial dysfunction","volume":"26","author":"Dragicevic","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12035-013-8491-x","article-title":"Involvement of alpha7 nAChR signaling cascade in epigallocatechin gallate suppression of beta-amyloid-induced apoptotic cortical neuronal insults","volume":"49","author":"Zhang","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12640-011-9249-8","article-title":"Curcumin attenuates aluminium induced oxidative stress and mitochondrial dysfunction in rat brain","volume":"20","author":"Sood","year":"2011","journal-title":"Neurotox. Res."},{"key":"ref_108","first-page":"202","article-title":"Metabolic Stress Induces Cognitive Disturbances and Inflammation in Aged Mice: Protective Role of Resveratrol","volume":"10","author":"Izquierdo","year":"2017","journal-title":"Rejuvenation Res."},{"key":"ref_109","first-page":"51","article-title":"Epigenetic targeting and personalized approaches for AML","volume":"44","author":"Roboz","year":"2014","journal-title":"Hematology"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Iglesias, O., Carrera, I., and Naidoo, V. (2022). Cacabelos AntiGan: An epinutraceutical bioproduct with antitumor properties in cultured cell lines. Life, 12.","DOI":"10.3390\/life12010097"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1570159X13666150211001600","article-title":"Epigenetic drugs for multiple sclerosis","volume":"14","author":"Peedicayil","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/jnc.13171","article-title":"Hippocampal chromatin-modifying enzimes are pivotal for scopolamine-induced synaptic plasticity gene expression changes and memory impairment","volume":"134","author":"Singh","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Atlante, A., Amadoro, G., Bobba, A., and Latina, V. (2020). Functional foods: An approach to modulate molecular mechanisms of Alzheimer\u2019s disease. Cells, 9.","DOI":"10.3390\/cells9112347"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/gps.4830","article-title":"Comparisons between traditional medicines and pharmacotherapies for Alzheimer disease: A systematic review and meta-analysis of cognitive outcomes","volume":"33","author":"May","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3233\/JAD-215423","article-title":"The efficacy and safety of Alzheimer\u2019s Disease Therapies: An updated umbrella review","volume":"85","author":"Fan","year":"2022","journal-title":"J. Alzheimer Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1021\/cn400044s","article-title":"Analysis of Glutamate, GABA, Noradrenaline, Dopamine, Serotonin and Metabolites using microbore UHPLC with Electrochemical Detection","volume":"15","author":"Reinhoud","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-4347(00)82012-5","article-title":"High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: Cation-exchange chromatography coupled with post-column derivatization fluorometry","volume":"344","author":"Yamatodani","year":"1985","journal-title":"J. Chromatogr."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Allison, J., Kaliszewska, A., Uceda, S., Reiriz, M., and Arias, N. (2021). Targeting DNA methylation in the adult brain through diet. Nutrients, 13.","DOI":"10.3390\/nu13113979"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","article-title":"Vitamin D and the risk of dementia and Alzheimer\u2019s disease","volume":"83","author":"Littlejohns","year":"2014","journal-title":"Neurology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/10408398.2011.621772","article-title":"Biocative Food Complements Platform. Polyphenols and the modulation of gene expression pathways: Can we eat our way out of the danger of chronic disease?","volume":"54","author":"Joven","year":"2014","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.3390\/nu6104625","article-title":"Nutrients intake is associated with DNA methylation of candidate inflammatory genes in a population of obese subjects","volume":"6","author":"Bollati","year":"2014","journal-title":"Nutrients"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/17460441.2018.1457645","article-title":"Have there been improvements in Alzheimer\u2019s disease drug discovery over the past 5 years?","volume":"13","author":"Cacabelos","year":"2018","journal-title":"Expert Opin. Drug Discov."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/11\/2447\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:16:54Z","timestamp":1760145414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/11\/2447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":122,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["pharmaceutics14112447"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14112447","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]}}}